Table 1.
“AND” group (n=46) | “DNR” group (n=47) | Total (n=93) | |
---|---|---|---|
Median age (range) | 64 (29–88) | 62 (31–88) | 62 (29–88) |
Men (%) | 15 (32.6) | 15 (31.9) | 30 (32.3) |
Caucasian (%) | 29 (63.0) | 26 (55.3) | 55 (59.1) |
College degree or higher (%) | 13 (28.3) | 13 (27.7) | 26 (28.0) |
Income | |||
<20,000 USD/year | 11 (23.9) | 8 (17.0) | 19 (20.4) |
21,000–50,000 USD/year | 13 (28.3) | 11 (23.4) | 24 (25.8) |
>50,000 USD/year | 11 (23.9) | 13 (27.7) | 24 (25.8) |
Cancer type | |||
Gastrointestinal | 11 (23.9) | 15 (31.9) | 26 (30.0) |
Genitourinary | 13 (28.3) | 9 (19.1) | 22 (23.7) |
Hematological | 8 (17.4) | 5 (10.6) | 13 (14.0) |
Breast | 6 (13.0) | 6 (12.8) | 12 (12.9) |
Lung | 5 (10.9) | 7 (14.9) | 12 (12.9) |
Sarcoma | 4 (8.7) | 2 (4.3) | 6 (6.4) |
Glioblastoma | 1 (2.2) | 2 (4.3) | 3 (3.2) |
Other | 2 (4.3) | 2 (4.3) | 4 (4.3) |
One or more comorbidities (%) | 23 (50.0) | 16 (34.0) | 39 (41.9) |